红细胞血型系统研究新进展*

doi:10.3969/j.issn.1671-2587.2022.02.001

临床输血与检验 ›› 2022, Vol. 24 ›› Issue (2): 137-141.DOI: 10.3969/j.issn.1671-2587.2022.02.001

• 红细胞血型专题 • 下一篇

红细胞血型系统研究新进展^*

杨东, 陈青

211166 南京医科大学（杨东）; 南京医科大学全球健康中心（陈青）; 江苏省血液中心（陈青）

收稿日期:2021-09-29 发布日期:2022-04-12
通讯作者: 陈青,女,研究员,博士,硕士生导师,主要从事输血医学研究工作,（E-mail）chenqing90@yahoo.com。
作者简介:杨东（1994-）,男,吉林延边人,学士,主要从事公共卫生与预防医学方面研究,（E-mail）1105522138@qq.com。
基金资助:
*本课题受江苏省“十三五”期间“科教强卫工程”医学重点人才（No.ZDRCB2016010）、江苏省重点研发计划社会发展项目（No.BE2015717）、江苏省高层次卫生人才“六个一工程”拔尖人才项目（No.LGY2017095）和江苏省第五期“333高层次人才培养工程”（No.2016-Ⅲ-3344）资助

Received:2021-09-29 Published:2022-04-12

摘要/Abstract

摘要： 血型研究在安全输血、胎儿和新生儿溶血性疾病、器官移植等方面具有重要临床意义。随着下一代基因组测序技术的迅猛发展,仅2020年就有5个新的红细胞血型系统得到正式命名,本文主要围绕CTL2（ISBT 039）、PEL（ISBT 040）、MAM（ISBT 041）、EMM（ISBT 042）、ABCC1（ISBT 043）这5个血型系统的研究进展进行综述。

关键词: CTL2血型系统, PEL血型系统, MAM血型系统, EMM血型系统, ABCC1血型系统

中图分类号:

R457

杨东, 陈青. 红细胞血型系统研究新进展^*[J]. 临床输血与检验, 2022, 24(2): 137-141.

[1] STORRY J R,JÖUD M,CHRISTOPHERSEN M K,et al. Homozygosity for a null allele of SMIM1 defines the Vel-negative blood group phenotype[J]. Nat Genet,2013,45(5):537-541.
[2] STORRY J R,CLAUSEN F B,CASTILHO L,et al.International society of blood transfusion working party on red cell immunogenetics and blood group terminology:report of the Dubai,Copenhagen and Toronto meetings[J]. Vox Sang,2019,114(1):95-102.
[3] DANIELS G,BALLIF B A,HELIAS V,et al.Lack of the nucleoside transporter ENT1 results in the Augustine-null blood type and ectopic mineralization[J]. Blood,2015,125(23):3651-3654.
[4] VRIGNAUD C, MIKDAR M, KOEHL B, et al.Alloantibodies directed to the SLC44A2/CTL2 transporter define two new red cell antigens and a novel human blood group system[J]. Transfusion, 2019, 59(suppl. s3): 18A.
[5] NAIR T S,KOZMA KE,HOEFLING NL,et al.Identification and characterization of choli ne transporter-like protein 2,an inner ear glycoprotein of 68 and 72 kDa that is the target of antibody-induced hearing loss[J]. J Neurosci,2004,24(7):1772-1779.
[6] KLEINMAN S, CAULFIELD T, CHAN P, et al.Toward an understanding of transfusion-related acute lung injury: statement of a consensus panel[J]. Transfusion, 2004, 44(12): 1774-1789.
[7] FLESCH B K,WESCHE J,BERTHOLD T,et al.Expression of the CTL2 transcript variants in human peripheral blood cells and human tissues[J]. Transfusion,2013,53(12):3217-3223.
[8] GREINACHER A,WESCHE J,HAMMER E,et al.Characterization of the human neutrophil alloantigen-3a[J]. Nat Med,2010,16(1):45-48.
[9] KOMMAREDDI P,NAIR T,KAKARAPARTHI B N,et al.Hair cell loss,spiral ganglion degeneration,and progressive sensorineural hearing loss in mice with targeted deletion of SLC44A2/Ctl2[J]. J Assoc Res Otolaryngol,2015,16(6):695-712.
[10] ALLEN B J,MASTRANGELO Michael A,TURE Sara K,et al.The choline transporter SLC44A2 controls platelet activation and thrombosis by regulating mitochondrial function[J]. Nat Commun,2020,11(1):3479.
[11] DANIELS G L,SIMARD H,GOLDMAN M,et al.PEL,a 'new' high-frequency red cell surface antigen[J]. Vox Sang,1996,70(1):31-33.
[12] AZOUZI S,MIKDAR M,HERMAND P,et al.Lack of the multidrug transporter MRP4/ABCC4 defines the PEL-negative blood group and impairs platelet aggregation[J]. Blood,2020,135(6):441-448.
[13] GENOMES PROJECT CONSORTIUM 1 0 0 0,AUTON A,BROOKS L D,et al. A global reference for human genetic variation[J]. Nature,2015,526(7571):68-74.
[14] SCHUETZ J D.“OMICs” reveal the molecular basis of a rare blood group[J]. Blood,2020,135(6):396-397.
[15] LOW F G,SHABIR K,BROWN J E,et al.Roles of ABCC1 and ABCC4 in proliferation and migration of breast cancer cell lines[J]. Int J Mol Sci,2020,21(20):7664.
[16] CHEEPALA S B,PITRE A,FUKUDA Y,et al.The ABCC4 membrane transporter modulates platelet aggregation[J]. Blood,2015,126(20):2307-2319.
[17] DECOUTURE B,DREANO E,BELLEVILLE-ROLLAND T,et al.Impaired platelet activation and cAMP homeostasis in MRP4-deficient mice[J]. Blood,2015,126(15):1823-1830.
[18] TEMPERILLI F,DI FRANCO M,MASSIMI I,et al.Nonsteroidal anti-inflammatory drugs in-vitro and in-vivo treatment and Multidrug Resistance Protein 4 expression in human platelets[J]. Vasc Pharmacol,2016,76:11-17.
[19] MONTGOMERY W M,NANCE S J,DONNELLY S F,et al.MAM:a “new” high-incidence antigen found on multiple cell lines[J]. Transfusion,2000,40(9):1132-1139.
[20] THORNTON N,CREW V K,TILLEY L,et al.Disrupti on of the tumour-associated EMP3 enhances erythroid proliferation and causes the MAM-negative phenotype[J]. Nat Commun,2020,11(1):3569.
[21] BEN-PORATH I,KOZAK C A,BENVENISTY N.Chromosomal mapping of Tmp (Emp1),Xmp (Emp2),and Ymp (EMP3),genes encoding membrane proteins related to Pmp22[J]. Genomics,1998,49(3):443-447.
[22] HAGEN S J.Non-canonical functions of claudin proteins:beyond the regulation of cell-cell adhesions[J]. Tissue Barriers,2017,5(2):e1327839.
[23] AHMAT AMIN M K B,SHIMIZU A,OGITA H. The pivotal roles of the epithelial membrane protein family in cancer invasiveness and metastasis[J]. Cancers,2019,11(11):1620.
[24] DANIELS G L,TALIANO V,KLEIN M T,et al.Emm. A red cell antigen of very high frequency[J]. Transfusion,1987,27(4):319-321.
[25] DUVAL R,NICOLAS G,WILLEMETZ A,et al.Inherited glycosylphosphatidylinositol defects cause the rare Emm-negative blood phenotype and developmental disorders[J]. Blood,2021,137(26):3660-3669.
[26] LANE W J,AESCHLIMANN J,VEGE S,et al.PIGG defines the Emm blood group system[J]. Sci Rep,2021,11(1):18545.
[27] KINOSHITA T.Biosynthesis and deficiencies of glycosylphosphatidylinositol[J]. Proc Jpn Acad Ser B Phys Biol Sci,2014,90(4):130-143.
[28] MAKRYTHANASIS P,KATO M,ZAKI M S,et al.Pathogenic variants in PIGG cause intellectual disability with seizures and hypotonia[J]. Am J Hum Genet,2016,98(4):615-626.
[29] WAGNER M M,VAN DUNNÉ F M,KUIPERS I,et al. Anti-Emm in a pregnant patient— case report[J]. Vox Sang,2014,106(4):385-386.
[30] OEPKES D,VAN KAMP I L,SIMON M J,et al. Clinical value of an antibody-dependent cell-mediated cytotoxicity assay in the management of Rh D alloimmunization[J]. Am J Obstet Gynecol,2001,184(5):1015-1020.
[31] FUJITA M,MAEDA Y,RA M,et al.GPI glycan remodeling by PGAP5 regulates transport of GPI-anchored proteins from the ER to the Golgi[J]. Cell,2009,139(2):352-365.
[32] PARSAMANESH N,SAFARPOUR H,ETESAM S,et al.Identification and in silico characterization of a novel point mutation within the phosphatidylinositol glycan anchor biosynthesis class G gene in an Iranian family with intellectual disability[J]. J Mol Neurosci,2019,69(4):538-545.
[33] SUGIER H, VRIGNAUD C, DUVAL R, et al.Null allele of ABCC1 encoding the multidrug resistance protein 1 defines a novel human blood group system[J]. Vox Sang, 2020, 115(suppl. s1): 40-41.
[34] COLE S P C. Targeting multidrug resistance protein 1 (MRP1,ABCC1):past,present,and future[J]. Annu Rev Pharmacol Toxicol,2014,54:95-117.
[35] COLE S P C. Multidrug resistance protein 1 (MRP1,ABCC1),a “multitasking” ATP-binding cassette (ABC) transporter[J]. J Biol Chem,2014,289(45):30880-30888.
[36] LESLIE E M.Arsenic-glutathione conjugate transport by the human multidrug resistance proteins (MRPs/ABCCs)[J]. J Inorg Biochem,2012,108:141-149.
[37] ROBEY R W,PLUCHINO K M,HALL M D,et al. Revisiting the role of ABC transporters in multidrug-resistant cancer[J]. Nat Rev Cancer,2018,18(7):452-464.
[38] FONSECA L M,ALVAREZ A B,RODRIGUES R C,et al.ABCC1 is related to the protection of the distal nephron against hyperosmolality and high sodium environment:possible implications for cancer chemotherapy[J]. PLoS One,2013,8(6):e68049.

红细胞血型系统研究新进展^*

RichHTML

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价

关于本刊

作者中心

在线期刊

访问统计

联系我们

[1]	张若洋, 杨东, 冯晨晨, 史丽莉, 李慧, 薛敏, 丁文艺, 陈青. 基因分型技术在ABO放散型亚型鉴定中的应用^*[J]. 临床输血与检验, 2022, 24(2): 142-146.
[2]	冯晨晨, 史丽莉, 李慧, 刘太香, 丁文艺, 陈青. c.955C>G变异致ABO等位基因增强现象的研究及文献复习^*[J]. 临床输血与检验, 2022, 24(2): 147-150.
[3]	牛佳萌, 李雪莲, 柳秋菊, 胡红兵, 屈柯暄, 杨江存. 全国住院输血新生儿凝血功能检测指标分析^*[J]. 临床输血与检验, 2022, 24(2): 151-156.
[4]	全雪丽, 王洁, 王风, 成怡冰, 洪小杨, 赵喆, 陈应富, 刘成军. 41例新生儿体外膜肺氧合期间血液成分输注的回顾性分析^*[J]. 临床输血与检验, 2022, 24(2): 197-201.
[5]	李正业, 王浩, 史玮, 高海燕, 马现君. 自体血小板分离回输技术对于不同血小板水平的主动脉夹层患者成分血输注量的影响研究[J]. 临床输血与检验, 2022, 24(2): 207-210.
[6]	张永生, 郑维威, 刘常青. 开放性输血策略与限制性输血策略对超低出生体重儿的存活和神经认知结局的影响:一项随机对照试验的系统综述和荟萃分析[J]. 临床输血与检验, 2022, 24(2): 211-217.
[7]	刘琴, 徐春芬, 宋婕, 谢松丽, 陈涵薇, 胡红兵. 输注不同治疗剂量血小板在56例急性淋巴细胞白血病患儿中的临床观察^*[J]. 临床输血与检验, 2022, 24(2): 218-221.
[8]	郑旭, 王凤华, 王田田, 程聪, 刘丰海. 限制性输血刍议[J]. 临床输血与检验, 2022, 24(2): 253-257.
[9]	董玉芳, 李萌, 陈雪. 血小板类产品细菌污染的预防、控制相关研究进展[J]. 临床输血与检验, 2022, 24(2): 258-263.
[10]	刘奇, 张彬. 血浆置换在自身免疫性疾病肾脏损伤中的治疗作用[J]. 临床输血与检验, 2022, 24(2): 264-267.
[11]	张嵘, 王文婷, 顾顺利, 胡兴斌, 尹文. 过客淋巴细胞综合征监测流程及输血策略探讨^*[J]. 临床输血与检验, 2021, 23(6): 681-685.
[12]	王倩, 杨李辉, 丁天凌, 夏荣. 自体造血干细胞移植中不同预处理方案与血小板输注的临床分析^*[J]. 临床输血与检验, 2021, 23(6): 686-692.
[13]	沈国栋, 栾建凤. 疑难血型肝衰竭患者紧急肝移植与输血策略——附1例报道[J]. 临床输血与检验, 2021, 23(6): 693-695.
[14]	陈学军, 王梦雅, 唐雀美, 沈月芳. 新生儿高胆红素血症换血治疗的现状及研究进展[J]. 临床输血与检验, 2021, 23(6): 696-699.
[15]	付晓艳, 张帅行, 邵华, 王孟键, 张慧敏, 马曙轩. 红细胞储存时间对体外循环心脏直视手术患儿血液指标的影响[J]. 临床输血与检验, 2021, 23(6): 700-703.